Affordable Access

Fincoid--a new copper IUD: a preliminary report.

Authors
Type
Published Article
Journal
Contraceptive delivery systems
Publication Date
Volume
3
Issue
2
Pages
83–89
Identifiers
PMID: 12338174
Source
Medline
Keywords
  • Acceptor Characteristics
  • Age Distribution
  • Bleeding
  • Clinical Research
  • Contraception
  • Contraception Termination--Statistics
  • Contraceptive Effectiveness
  • Contraceptive Methods
  • Copper
  • Developed Countries
  • Economic Factors
  • Equipment And Supplies
  • Europe
  • Examinations And Diagnoses
  • Family Planning
  • Finland
  • Ingredients And Chemicals
  • Inorganic Chemicals
  • Insertion
  • Iud
  • Iud Material
  • Metals
  • Northern Europe
  • Nulliparity
  • Pain
  • Parity
  • Polyethylene
  • Pregnancy
  • Pregnancy Rate
  • Pregnancy, Ectopic
  • Research And Development
  • Research Methodology
  • Retention--Statistics
  • Scandinavia
  • Size
  • Technology
  • Use-Effectiveness

Abstract

Fincoid, a new copper IUD, was tested on a single clinic basis in a preliminary series of 956 1st insertions and 10,015 woman-months of use with an individual follow-up of 12 months. 458 (48%) of the women were nulliparous and 498 (52%) were parous. About 1/3 of the women had previously discontinued the use of other types of IUDs (mostly copper) because of side effects. The 1st segment of net cumulative rates for the whole series were: pregnancy 1.1, expulsion 4.7, removal for bleeding and/or pain 7.6 and removal for infection 0.8. The continuation rate was 78.9 and the percentage lost to follow-up was 2.8%. The parous group had a higher continuation rate (81) than the nulliparous group (76). Rates for pregnancy, expulsion, and infection in the nulliparous group were about 2-fold the corresponding rates of the parous group. There was no difference in the removal rate for bleeding and/or pain between the 2 parity groups. The results of the study show that the Fincoid is a valid method of intrauterine contraception.

There are no comments yet on this publication. Be the first to share your thoughts.

Statistics

Seen <100 times
0 Comments